DopaMINE Study - Exploring Self, Ownership & Reward in ADHD and Neurotypical Controls

You have been invited to take part in the study because you have had a recent ADHD diagnosis from the Avon and Wiltshire Partnership ADHD clinic in Bristol but have not yet been prescribed medication.

Study Background

ADHD has been linked to low levels of the neurotransmitter dopamine in the brain. This affects attention, memory, movement and self-control, all of which are associated with ADHD symptoms. A formal diagnosis will likely result in the prescription of stimulant medication (for example, Ritalin, Elvanse, Vyvanse) to change the dopamine levels in parts of your brain in order to reduce these symptoms. It is important to be able to measure brain levels of dopamine accurately and efficiently. Dopamine can be detected in samples of tears and blood, but it is not clear whether this tells us what is going on in the brain. By comparing samples taken with and without medication you will be helping us to understand how useful this technique is for investigating the brain. We will also explore how your medication dose directly affects your brain, body, and behaviour.

Please take time to watch the study information video below and to read any additional details about the study and discuss it with others if you wish. Remember that your participation is voluntary.

Study Information

The following video introduces the study:

Please use the link above to view more study details and how to register to take part. Please take time to read the inclusion and exclusion criteria for the study. If you are eligible to take part you can register here.  We will then get in touch with you to arrange a testing session in our lab at the university of Bristol.